Nuo Therapeutics, Inc. Sustainability Profile
Nuo Therapeutics, Inc., a pioneering company in the regenerative medicine sector, is headquartered in the United States. Founded in 2010, Nuo Therapeutics focuses on developing innovative therapies for chronic wounds and other tissue-related conditions, leveraging its expertise in cell-based technologies. The company’s flagship product, Aurix™, is a unique autologous cell therapy that harnesses the body’s own healing capabilities, setting it apart in the competitive landscape of wound care solutions. Nuo Therapeutics has achieved significant milestones, including regulatory approvals and partnerships that enhance its market presence. With a commitment to advancing patient care, Nuo Therapeutics continues to solidify its position as a leader in the regenerative medicine industry, dedicated to improving outcomes for patients worldwide.
DitchCarbon Score
How does Nuo Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nuo Therapeutics, Inc.'s score of 23 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Nuo Therapeutics, Inc.'s reported carbon emissions
Nuo Therapeutics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Nuo Therapeutics may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, Nuo Therapeutics may need to consider developing and communicating its climate commitments to align with broader environmental goals.
How Carbon Intensive is Nuo Therapeutics, Inc.'s Industry?
How Carbon Intensive is Nuo Therapeutics, Inc.'s Location?
Nuo Therapeutics, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Nuo Therapeutics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
